Overview of Dataderm Data Sources, Content, Limitations, and Research Uses

Conclusions

• DataDerm is strongest as a real-world registry of private-practice dermatology care rather than a fully comprehensive national dermatology data source.
• Its main value comes from direct EHR feeds, which provide large-scale, longitudinal, visit-level data on demographics, diagnoses, procedures, medications, and practice patterns.
• Because the registry inherits whatever is documented in participating EHRs, the data are messy and heterogeneous and require substantial cleaning and question-specific processing.
• Important data elements such as external labs, images, PDFs, billing outcomes, scheduling, referrals, and many structured outcome measures are either missing or inconsistently captured.
• Comorbidity, vital sign, non-dermatologic medication, and patient-reported data should be interpreted cautiously because they are underdocumented or unevenly available.
• The registry is geographically broad and large enough to support studies of common conditions, rare conditions, and longitudinal care trajectories.
• The current participant mix skews toward small-to-medium private practices, adult patients, female patients, privately insured patients, and white patients, so generalizability is limited for some populations.
• DataDerm is best suited for retrospective observational research, descriptive analyses, treatment-pattern studies, geographic access questions, and investigations of patient subgroups over time.
• It is not well suited to prospective study designs or analyses that depend on consistently collected outcome instruments or complete claims-like information.
• The dataset can be strengthened by supplementing it with public data sources, and its usefulness should expand as more academic and health-system practices join the registry.